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Abstract Little evidence exists regarding the need for a
reduction in postoperative heart rate after repair of type A
acute aortic dissection. This single-center retrospective
study was conducted to determine if lower heart rate during
the early postoperative phase is associated with improved
long-term outcomes after surgery for patients with type A
acute aortic dissection. We reviewed 434 patients who
underwent aortic repair between 1990 and 2011. Based on
the average heart rate on postoperative days 1, 3, 5, and 7,
434 patients were divided into four groups, less than 70,
70–79, 80–89, and greater than 90 beats per minute. The
mean age was 63.3 ± 12.1 years. During a median follow-
up of 52 months (range 16–102), 10-year survival in all
groups was 67 %, and the 10-year aortic event-free rate
was 79 %. The probability of survival and being aortic
event-free using Kaplan–Meier estimates reveal that there
is no significant difference when stratified by heart rate.
Cox proportional regression analysis for 10-year mortality
shows that significant predictors of mortality are age
[Hazard Ratio (HR) 1.04; 95 % confidence interval (CI)
1.07–1.06; p = 0.001] and perioperative stroke (HR 2.30;
95 % CI 1.18–4.50; p = 0.024). Neither stratified heart
rate around the time of surgery nor beta-blocker use at the
time of discharge was significant. There is no association
between stratified heart rate in the perioperative period
with long-term outcomes after repair of type A acute aortic
dissection. These findings need clarification with further
clinical trials.
Keywords Aortic dissection  Heart rate  Outcomes 
Surgery
Introduction
Acute aortic dissection (AAD) is a lethal cardiovascular
disease. Despite continuing improvements in surgical and
medical management, the 10-year survival rate in patients
with type A AAD has remained low at 53.4–67.7 % [1–5].
Medical therapy to reduce blood pressure (BP) and heart rate
in patients with AAD is widely used. Among medications,
treatment with beta-blockers is reported as the key medical
therapy by lowering both BP and cardiac contractility [6–8].
Heart rate is simply used as a surrogate of the degree of
antiadrenergic and anti-inotropic effect of the drug therapy.
Only one study has evaluated the efficacy of tight heart rate
control in patients with type B AAD, which showed that the
probability of aortic event-free survival was significantly
higher in the tight heart rate control group compared with the
conventionally managed heart rate group [8]. However, little
evidence exists regarding the need for a reduction in post-
operative heart rate after repair of type A AAD.
We conducted this study to evaluate whether a lower
heart rate during the early postoperative phase improves
the long-term outcomes after surgical repair of type A
AAD.
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We retrospectively reviewed 434 patients who underwent
surgical repair of a type A AAD at Jichi Medical Univer-
sity Saitama Medical Center between 1990 and 2011.
Operations were performed urgently in all patients within
14 days of the onset of symptoms. The ethics committee
approved this study, and the requirement for informed
consent was waived. Patients who died within 6 days after
surgery or had missing data, were excluded. Aortic dis-
section was proven by enhanced computed tomography,
and defined as according to the Stanford and DeBakey
classifications. We used data from the first operation during
the hospitalization if more than one operation was per-
formed. Preoperative variables evaluated in this study
include age, gender, smoking, past medical history
(hypertension, diabetes, dyslipidemia, chronic obstructive
pulmonary disease, myocardial infarction, cardiac opera-
tion and bicuspid aortic valve), hypotension, aortic regur-
gitation, surgical parameters (duration of cardiopulmonary
bypass, aortic cross clamp time, use of deep-hypothermic
circulatory arrest), and laboratory data (hemoglobin and
serum creatinine level). Postoperative events and outcomes
include: the need for reoperation, aortic rupture in the
hospital, atrial fibrillation, renal replacement therapy,
stroke, prolonged ventilation (defined as the requirement
ventilation for more than 48 h), tracheostomy, ICU length
of stay, hospital length of stay and in-hospital mortality.
Medical management and long-term follow-up
Intravenous beta-blockers and/or calcium channel blockers
were administered to reduce systolic BP\ 120 mmHg as
initial therapy in the ICU after surgical repair. Intravenous
medications were replaced by oral antihypertensive drugs
including calcium channel blockers, beta-blockers, angio-
tensin-converting enzyme inhibitors, angiotensin receptor
blockers and diuretics, as appropriate. The decision to give
oral antihypertensive medications was at the discretion of
the treating physician.
Heart rate and BP at 6 a.m., 2 p.m., and 8 p.m. daily
during the hospitalization were recorded. Based on the
average heart rate on postoperative days 1, 3, 5, and 7, 434
patients were divided into four groups, A: \70 beats per
minute (bpm), B: 70–79 bpm, C: 80–89 bpm, and D:
[90 bpm.
Follow-up data including survival time and cause of
death once in every 3 years after repair of type A AAD
were obtained by mailing a questionnaire to all patients. If
responses were not returned, we contacted the patient, the
patient’s family or the family physician by telephone.
Aortic events were defined as aortic rupture, secondary
operation, endovascular stenting, late organ ischemia or
sudden death [8].
Statistical analysis
Data are presented as mean ± standard deviation, medians
(interquartile ranges, IQR) or percentages, as appropriate.
Either Chi-square or Fisher’s exact test was used for
nominal variables, and one-way analysis of variance was
used to compare continuous variables. The Kruskal–Wallis
test was used for nonparametric variables. A p value of
\0.05 was considered statistically significant. Cox pro-
portional hazard analysis was conducted to identify inde-
pendent risk factors for 10-year mortality and aortic events.
Cumulative 10-year survival rate and aortic event-free rate
stratified by heart rate were analyzed with Kaplan–Meier
analysis using the Log-rank test. All analysis was per-
formed using SPSS 19.0 (IBM, USA).
Results
Four hundred and seventy patients underwent surgical
repair of type A AAD. Twenty-six patients died within
6 days and data of 10 patients were missing, as shown in
Fig. 1 Patients included in the study, and the schema for classifica-
tion into study Groups A, B, C and D, stratified by heart rate (bpm-
beats per minute)
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Fig. 1. Among the remaining 434 patients, the median
follow-up period was 52 (IQR 16–102) months. The mean
age was 63.3 ± 12.1 years, and the male: female ratio was
51:49. Preoperative comorbidities included hypertension
(70 %), diabetes (6 %), dyslipidemia (18 %), chronic
obstructive pulmonary disease (3 %), previous myocardial
infarction (5 %), previous cardiac operation (1 %), Marfan
syndrome (3 %), bicuspid aortic valve (1 %), hypotension
(29 %), and aortic regurgitation (12 %).
Surgical procedures performed included hemi-arch
replacement (23 %), aortic arch replacement (14 %), aortic
valve replacement (1 %), aortic root replacement with
Bentall procedure (4 %), coronary artery bypass grafting
(7 %), and entry resection (73 %). The durations of oper-
ation, cardiopulmonary bypass time, aortic cross clamp
time, and deep-hypothermic arrest time were 371 ± 128,
146 ± 52, 103 ± 39, and 35 ± 15 min, respectively.
Postoperative complications included prolonged ventilation
([48 h) (40 %), atrial fibrillation (37 %), perioperative
stroke (10 %), re-exploration for bleeding (6 %), need for
renal replacement therapy (6 %), tracheostomy (4 %), and
early postoperative aortic rupture (1 %).
The 434 patients were divided into four groups for
further analysis based on their heart rate, including 19
patients (4 %) in Group A (heart rate \70 bpm), 87
patients (20 %) in Group B (70–79 bpm), 162 patients
(37 %) in Group C (80–89 bpm), and 166 patients (38 %)
in Group D ([90 bpm). No patient had an average heart
rate less than 60 bpm. Postoperative average systolic and
diastolic BP were 121 ± 10, 69 ± 7 mmHg, respectively.
Tables 1 and 2 showed baseline and perioperative details
categorized by the heart rate group. Significant differences
between the four groups were seen in regard to dyslipide-
mia, preoperative serum creatinine, operative time, re-
exploration for bleeding, atrial fibrillation, need for renal
replacement therapy, prolonged ventilation, and postoper-
ative average diastolic BP. ICU length of stay and hospital
length of stay were also significantly different among the
groups by univariate analysis.
The postoperative medications are shown in Table 3.
Most patients in the study (91 %) required at least one
antihypertensive medication at the time of discharge,
which included beta-blockers (54 %), angiotensin-con-
verting enzyme inhibitors (11 %), angiotensin receptor
blockers (32 %), calcium channel blockers (62 %), and
diuretics (28 %). Beta-blocker use was significantly asso-
ciated with a lower heart rate (p\ 0.001).
Cumulative survival rate from the time of admission in
all groups was 97 % at 1 month, 93 % at 1 year, 81 % at
5 years, and 67 % at 10 years. Cumulative aortic event-
Table 1 Baseline
characteristics of patients with
type A acute aortic dissection
categorized by heart rate
(n = 434)
COPD chronic obstructive
pulmonary disease, AR aortic
regurgitation
Variable Heart rate (bpm)
\70 70–79 80–89 [90 p value
Patient number 19 87 162 166
Characteristics
Male (%) 52.6 48.3 51.9 51.2 0.96
Age (years) 65 ± 10 64 ± 10 63 ± 13 63 ± 13 0.93
Smoking (%) 47.4 49.4 48.1 45.2 0.91
Medical history
Hypertension (%) 89.5 75.9 67.9 66.9 0.11
Diabetes (%) 5.3 3.4 4.9 7.8 0.51
Dyslipidemia (%) 15.8 32.2 11.7 16.3 0.001
COPD (%) 0 1.1 2.5 4.8 0.41
Previous myocardial infarction (%) 10.5 4.6 3.7 4.8 0.61
Previous cardiac operation (%) 0 1.1 1.9 1.2 0.91
Marfan syndrome (%) 0 1.1 3.1 3.0 0.87
Bicuspid aortic valve (%) 0 2.3 0.6 0.6 0.45
Preoperative laboratory data
Serum creatinine (mg/dl) 1.9 ± 2.8 1.2 ± 1.4 1.0 ± 0.6 1.0 ± 0.8 0.002
Hemoglobin (g/dl) 12.4 ± 2.0 12.1 ± 1.8 12.3 ± 2.0 12.3 ± 1.9 0.75
Preoperative shock (%) 15.8 26.4 33.3 27.7 0.36
Preoperative AR (%) 10.5 11.5 9.9 15.1 0.56
DeBakey classification
Type I (%) 73.7 63.2 58.6 68.1 0.26
Type II (%) 5.3 11.5 16.7 7.2 0.05
Type IIIb retrograde (%) 21.1 23.0 24.1 24.7 0.98
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free rate in all groups was 98 % at 1 month, 96 % at
1 year, 91 % at 5 years, and 79 % at 10 years. The prob-
ability of 10-year survival categorized by heart rate using
Kaplan–Meier analysis reveals no significant differences
among the groups (A vs. B, p = 0.815; A vs. C, p = 0.335;
A vs. D, p = 0.415), as shown in Fig. 2. The probability of
being 10-year aortic event-free was also not significantly
different among the groups (A vs. B, p = 0.269; A vs. C,
p = 0.352; A vs. D, p = 0.261), as shown in Fig. 3. Cox
proportional regression analysis for 10-year mortality
showed that significant predictors of mortality include age
[Hazard Ratio (HR) 1.04; 95 % confidence interval (CI)
1.07–1.06; p = 0.001] and perioperative stroke (HR 2.30;
95 % CI 1.18–4.50; p = 0.024) (Table 4). Neither strati-
fied heart rate nor beta-blocker use was significant. Cox
proportional regression analysis for 10-year aortic events
was also performed. Only a diagnosis of Marfan syndrome
was a significant risk factor in that model (HR 6.59; 95 %
CI 2.57–16.87; p\ 0.001).
Discussion
In this study, we examined the association of heart rate,
stratified into four groups, in the early postoperative period
with long-term outcomes after repair of type A AAD. The
key findings showed that there is no significant difference
Table 2 Intraoperative and
postoperative details and short-
term outcomes of patients with
type A acute aortic dissection




coronary artery bypass graft,
SBP systolic blood pressure,
DBP diastolic blood pressure
Variable Heart rate (bpm)
\70 70–79 80–89 [90 p value
Surgery characteristics
Operation time (min) 351 ± 125 337 ± 96 363 ± 114 398 ± 150 0.003
CPB time (min) 148 ± 72 142 ± 45 142 ± 48 151 ± 59 0.34
Aorta cross clamp time (min) 106 ± 50 105 ± 35 101 ± 34 103 ± 44 0.89
DHCA time (min) 35 ± 20 35 ± 14 35 ± 14 34 ± 16 0.99
Hemi-arch replacement (%) 26.3 31.0 22.8 17.5 0.10
Aortic arch replacement (%) 21.1 13.8 9.9 16.9 0.20
Aortic valve replacement (%) 5.3 0 1.2 1.2 0.29
Bentall (%) 0 3.4 4.9 3.6 0.89
CABG (%) 0 6.9 4.9 9.6 0.29
Entry resection (%) 78.9 75.9 72.8 71.5 0.83
Re-exploration for bleeding (%) 0 1.1 4.3 9.6 0.024
Postoperative events
Aortic rupture in hospital (%) 0 1.1 0.6 0.6 1.00
Atrial fibrillation (%) 15.8 29.9 34.0 46.7 0.005
Renal replacement therapy (%) 10.5 3.4 3.1 9.6 0.037
Perioperative stroke (%) 10.5 8.0 8.6 13.3 0.49
Prolonged ventilation (%) 47.4 32.6 33.8 50.0 0.008
Tracheostomy (%) 0 4.6 3.7 3.0 0.85
Postoperative average SBP (mmHg) 118 ± 9 121 ± 10 121 ± 11 121 ± 10 0.54
Postoperative average DBP (mmHg) 65 ± 8 67 ± 6 69 ± 7 70 ± 7 \0.001
Short-term outcomes
ICU stay (days) 5 (3–10) 5 (4–7) 5 (4–7) 7 (5–10) \0.001
Hospital stay (days) 20 (15–31) 20 (16–28) 23 (18–30) 25 (19–35) 0.005
Hospital mortality (%) 0 2.3 5.6 4.2 0.63
Table 3 Postoperative medications
Heart rate (bpm)





52.1 73.7 70.6 58.2 32.7 \0.001
At discharge (%) 53.8 68.4 68.2 59.5 39.0 \0.001
ACE inhibitors at
discharge (%)
11.3 15.8 8.2 9.2 14.5 0.31
ARB at discharge
(%)
32.2 52.6 44.7 28.1 27.0 0.006
CCBs at discharge 62.5 78.9 68.2 58.8 61.0 0.23
Diuretics at
discharge
27.6 26.3 14.1 27.5 35.2 0.004
ACE angiotensin-converting enzyme, ARB angiotensin receptor
blocker, CCB calcium channel blocker
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in 10-year survival among the four groups using Kaplan–
Meier analysis, nor is there a difference in the probability
of being 10-year aortic event-free. Cox regression analysis
showed that significant predictors of 10-year mortality
include age and perioperative stroke. Only a diagnosis of
Marfan syndrome was significant in the model for 10-year
aortic events. Neither stratified heart rate nor any medica-
tion was a significant predictor for both 10-year mortality
and aortic events.
Patients with Type A AAD usually undergo surgical
repair, and postoperative medical therapy is routinely given
to stabilize the aortic wall and prevent aortic rupture and
recurrent dissection [9]. Medical management of AAD was
proposed in classic studies in the 1960s [10, 11]. In those
studies, authors established two primary goals of medical
therapy including reduction in BP and diminution of left
ventricular ejection force (dp/dt). Among medications,
beta-blockers have been a key drug for the control of both
dp/dt and BP by reducing both the heart rate and BP [12].
Reasonable targets for heart rate and systolic BP have been
less than 60 bpm and between 100 and 120 mm Hg,
respectively [12]. Until the present, however, use of these
medical therapies for AAD has not been supported by solid
clinical evidence.
There is only one study that investigated the effect of
tight heart rate control in patients with type B AAD [8].
Kodama and colleagues retrospectively collected 171
patients with type B AAD treated medically in a single
center between 1997 and 2005. Based on the average heart
rate at 3, 5, and 7 days after the onset, patients were
divided into a tight heart rate management group
(\60 bpm, n = 32) and a control group (C60 bpm,
n = 139). The main outcome of Kaplan–Meier analysis for
aortic event-free survival (median follow-up 27 months)
showed that the tight heart rate control group had a sig-
nificantly higher rate of being aortic event-free than the
conventional heart rate control group (p = 0.017). In
comparison, the current study did not show a significant
difference in long-term outcomes when stratified by heart
rate. While this discrepancy may be caused by physiologic
differences between type A AAD and type B AAD, studies
to date have not conclusively shown whether or not we
need to further reduce the heart rate.
In patients who underwent repair of type A AAD, little
was known about the effects of medical therapy on long-
Fig. 2 Kaplan–Meier curves for overall 10-year survival in patients
with type A acute aortic dissection, stratified by heart rate
Fig. 3 Kaplan–Meier curves for 10-year aortic event-free survival in
patients with type A acute aortic dissection, stratified by heart rate
Table 4 Multivariate analysis of risk factors for 10-year mortality
and aortic events
p value Hazard ratio 95 % CI
Variable
10-year mortality
Age 0.001 1.038 1.016–1.061
Perioperative stroke 0.015 2.302 1.177–4.503
10-year aortic events
Marfan syndrome \0.001 6.591 2.574–16.872
CI confidence interval
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term survival [13, 14]. In contrast, there have been several
studies to evaluate the long-term outcomes of medical
therapy in patients with type B AAD [7, 8, 13, 15–17].
Suzuki and colleagues [13] investigated the effects of
medications on long-term outcomes in 1301 patients (722
with type A and 579 with type B) using the International
Registry of Acute Aortic Dissection (IRAD) database from
1995 with follow-up to 5 years. The results of multivariate
analysis of 654 surgically treated patients with type A
AAD showed that beta-blocker use was significantly
associated with lower mortality (HR 0.47, 95 % CI
0.25–0.90, p = 0.02). Calcium channel blockers and
renin–angiotensin system inhibitors were not included in
their model. There have been reports that calcium channel
blockers’ use is significantly associated with improved
outcomes for patients with type B AAD [13, 16].
Regarding the present study, however, no other studies
have shown a positive effect of long-term calcium channel
blockers’ use on patients with type A AAD. Although
renin–angiotensin system inhibitors might be useful in
patients with Marfan syndrome and aortic aneurysms [18,
19], no evidence exists regarding the effects of these
medications on patients with Type A AAD.
As previously mentioned, BP control is the other pri-
mary goal of medical therapy in patients with type A AAD.
A recent single-center study evaluated the impact of BP on
25-year outcomes following repair of type A AAD between
1984 and 2009 [3]. Based on the BP at late follow-up, all
252 patients were divided into three groups: systolic
BP\ 120, 120–140, and [140 mmHg. Patients who
maintained a systolic BP\ 120 mmHg had improved
freedom from reoperation compared with those having a
BP 120–140 or[140 mmHg (p\ 0.001) by Kaplan–Meier
analysis. The present study failed to show an association
between postoperative systolic BP in the acute phase and,
either 10-year mortality, or being aortic event-free, by Cox
regression analysis. Although, we have not been able to
investigate the effect of the late-phase BP in the type A
AAD patients reviewed here, late follow-up of BP might be
an important factor in addition to postoperative BP.
Marfan syndrome is one of the major inherited con-
nective tissue disorders that may lead to the weakening of
the aortic media, and subsequently to AAD, aortic aneu-
rysm or rupture. Previous clinical trials showed that Marfan
syndrome was one of the risk factors for late aortic events
[20, 21]. In the current study, Marfan syndrome was
included among the risk factors for the occurrence of long-
term aortic events. This might be partially explained by the
fact that the dissected aortic wall in patients with Marfan
syndrome tends to develop aneurysmal dilatation due to
wall weakness, more than in type A AAD patients [22].
There are several acknowledged limitations to this study.
Most importantly, we evaluated only the acute phase of the
average heart rate and BP on postoperative days 1, 3, 5, and
7, and we did not investigate the heart rate, BP or medi-
cations during long-term follow-up. Approximately, half of
the patients after discharge are followed at regular hospital
visits, and the remaining patients are followed in other
hospitals or clinics. Thus, data for only about half of the
patients regarding heart rate, BP, and medications are
available after discharge from the hospital. The protective
factor of heart rate and BP is likely cumulative over time.
The time points during the acute postoperative period may
not be adequate surrogates for long-term control of heart
rate, because the long-term heart rate and BP are probably
different compared to those in the immediate postoperative
period. These parameters may contribute to the failure to
show a long-term difference in survival. Secondly, the
present study is a single-center retrospective study.
Although the sample size is not small compared with pre-
vious studies reporting long-term outcomes in patients with
type A AAD [1–5, 20, 23–25], these findings may be limited
in application to other type A AAD patients because of the
relatively homogenous population. Thirdly, the control of
heart rate was not sufficient in our population because no
one achieved less than 60 bpm and only 19 patients were
less than 70. Although patients with beta-blockers tended to
have a lower heart rate as shown in Table 3, it is difficult to
reduce the heart rate after surgical repair due to multiple
factors including, inflammation, infection, and atrial fibril-
lation. Fourthly, class effects and dosages of the each
medication were not reviewed in this study. We did not test
the effect of the combination of drugs that might have more
synergy. Furthermore, there was a lack of information
regarding additional medications and compliance. The
medications at discharge may have been changed later in
the study period. It is acknowledged that the medication list
at the time of discharge may not adequately reflect long-
term medication usage in the study population. Finally, the
choice of antihypertensive drugs was made by the individ-
ual treating physicians. Selection bias potentially occurred
even after adjusting for the risk factors.
Conclusions
We did not observe a difference in the long-term mortality
or incidence of aortic events in patients after repair of type
A AAD, when stratified by heart rate during the acute
hospitalization. There are several possible explanations for
this observation. It remains unknown whether lower heart
rate is important for outcomes. These findings suggest the
need for further study in randomized clinical trials.
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